What is the global market size of Bone Graft Substitutes Market?

Bone Graft Substitutes Market size was valued at USD 2.80 Billion in 2022 and is poised to grow from USD 2.98 Billion in 2023 to USD 4.85 Billion by 2031, at a CAGR of 6.30% during the forecast period (2024-2031).

Bone Graft Substitutes Market Updates

Bone Graft Substitutes Market News

In May 2024, Irvine-based Biogennix, LLC, an osteobiologics company, has announced the receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of its Agilon Moldable and Morpheus Moldable bone grafting products.
In Jan 2024, Cerapedics Inc., an orthopedics company at the forefront of bone repair innovation, has announced the submission of the final module in their Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the P-15 Peptide Enhanced Bone Graft. This submission marks a significant milestone for Cerapedics, as it could lead to the approval of their second Class III drug/device combination product designed for lumbar spine fusion with a TLIF indication.
In October 2023, Orthofix Medical Inc. (NASDAQ:OFIX), a global leader in spine and orthopedics, has announced the 510k clearance and full commercial launch of OsteoCove™, a cutting-edge bioactive synthetic graft.
In May 2023, Zimmer Biomet Holdings, Inc. announced the launch of its VIVIX 3D Printed Bone Matrix, a breakthrough bone graft substitute with a porous structure designed to mimic the natural bone environment.
In April 2023, Stryker Corporation acquired NuVasive, Inc., a leading provider of spine surgery solutions, expanding its product portfolio in the bone graft substitutes market and strengthening its presence in the spine care segment.
In February 2023, Osseus Fusion Systems received FDA clearance for its ARIES-TS spinal implant system, designed for use with autograft or bone graft substitutes in posterior lumbar interbody fusion (PLIF) surgeries.
In December 2022, Kuros Biosciences announced a collaboration with Johnson & Johnson Medical Devices Companies to co-develop innovative orthobiologic solutions for bone graft substitutes and regenerative medicine.
In September 2022, SeaSpine Holdings Corporation launched the Mariner MIS Posterior Fixation System, an innovative platform that combines pedicle screw fixation and bone grafting options for minimally invasive spinal fusion procedures.

FAQs

Bone Graft Substitutes Market size was valued at USD 1.28 Billion in 2023 and is poised to grow from USD 1.37 Billion in 2024 to USD 2.29 Billion by 2032, growing at a CAGR of 6.70% during the forecast period (2025-2032).

Global bone graft substitutes market is characterized by a diverse range of market players, including both established companies and emerging players. These players are focused on research and development activities to introduce innovative bone graft substitutes that offer enhanced biocompatibility, safety, and efficacy. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are common strategies adopted by companies to strengthen their market position. The competitive landscape is driven by a continuous quest for technological advancements and the development of cost-effective solutions that cater to the evolving needs of healthcare providers and patients. 'AlloSource (US)', 'Smith + Nephew (UK)', 'Medtronic (Ireland)', 'Orthofix US LLC (US)', 'Pietro Fiorentini S.p.A. (Italy)', 'TBF (France)', 'OST Laboratories (France)', 'Geistlich Pharma AG (Switzerland)', 'Stryker (US)', 'Biobank (UK)', 'Aichi Tokei Denki Co., Ltd. (Japan)', 'Chongqing Shancheng Gas Equipment Co., Ltd. (China)', 'Flonidan A/S (Denmark)', 'EMH metering GmbH & Co. KG (Germany)', 'Badger Meter, Inc. (US)', 'Wasion Group Holdings Limited (Star Treasure Investments Holdings Limited) (China)', 'Holley Technology Ltd. (Holley Group) (China)', 'Qianwei Kromschroder Meters Co., Ltd. (China)', 'Secure Meters Limited (India)', 'IMAC Systems, Inc. (US)', 'Metrix Meter (Poland)'

One significant driver in the global bone graft substitutes market is the increasing prevalence of orthopaedic conditions and musculoskeletal disorders. Factors such as sedentary lifestyles, aging population, sports-related injuries, and accidents contribute to the rising incidence of fractures and bone-related ailments. As a result, there is a growing demand for effective bone graft substitutes to aid in bone regeneration and healing. This driver highlights the need for innovative solutions in the market to cater to the increasing patient pool and address the challenges associated with orthopaedic conditions.

One key market trend in the global bone graft substitutes market is the growing focus on the development of bioactive and tissue-engineered graft substitutes. These advanced graft substitutes offer improved biocompatibility and promote faster bone healing. The integration of technologies such as 3D printing and nanotechnology has enabled the creation of customized graft substitutes with enhanced structural and mechanical properties. This trend highlights the industry's commitment to innovation and the pursuit of solutions that can mimic natural bone tissue, leading to improved patient outcomes and reduced complications in bone graft procedures.

North America dominated the global bone graft substitutes market. The region's dominance can be attributed to several factors, including advanced healthcare infrastructure, high healthcare expenditure, favorable reimbursement policies, and extensive research and development activities. The United States, in particular, plays a major role in driving market growth in North America, with a well-established healthcare system and a large patient population. Furthermore, the presence of key market players and their focus on developing innovative bone graft substitutes contribute to the region's dominance.